FASLG and autoimmune polyendocrinopathy: Our results have provided direct evidence that human aDI is prothrombotic in vivo, thus emphasizing the importance of measuring circulating aDI for APS diagnosis and further highlighting the therapeutic potential of recombinant DI as a decoy for pathogenic aPL.